Agios Pharmaceuticals (NASDAQ:AGIO) just reported results for the first quarter of 2024.
- Agios Pharmaceuticals reported earnings per share of -$1.45. This was above the analyst estimate for EPS of -$1.65.
- The company reported revenue of $8.19 million.
- This was 2.16% worse than the analyst estimate for revenue of $8.37 million.